Patent · US Active

Composition for intraocular implantation of bevacizumab

US9186414B2 · kind B2 · utility

0Cited by

1References

26Claims

0Family size

Assignee

UCL BUSINESS PLC · GB

Inventors

Peng Tee Khaw · London, GB
Stephen James Brocchini · Highland Park, US
Ashkan Khalili · Addison, US

Key dates

Filing date	Oct 7, 2011
Grant date	Nov 17, 2015
Priority date	—
Expiry date	Oct 7, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A solid, compressed pharmaceutical composition comprises i) a peptide active pharmaceutical ingredient, ii) a polysaccharide excipient and/or an albumin, and iii) an oligosaccharide excipient. The polysaccharide excipient may be hyaluronic acid, or the potassium salt thereof, and the oligosaccharide excipient may be trehalose.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.